Cite Filings / RARE / 0001193125-19-112719
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

Ultragenyx Pharmaceutical Inc. · Filed 2019-04-22 · Acc 0001193125-19-112719

Documents 1

  • DEF 14A Proxy Statement , d727791ddef14a.htm

Around this filing

  • 2020-04-29 DEF 14A Proxy Statement
  • 2019-04-23 4 President & CEO gave up 798 shares (to pay taxes)
  • 2019-04-23 4 VP, Controller and PAO gave up 138 shares (to pay taxes)
  • 2019-04-23 4 EVP & Chief Tech Ops Officer gave up 248 shares (to pay taxes)
  • 2019-04-22 DEFA14A Proxy Materials
  • 2019-04-22 DEF 14A Proxy Statement
  • 2018-04-27 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d727791ddef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…